Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Reata Pharmaceuticals Inc sell BiotechBee

Start price
€38.40
25.01.23 / 70%
Target price
€25.00
29.02.24
Performance (%)
11.46%
Price
€42.80
10:09
Summary
This prediction is currently active. The prediction currently has a disappointing performance of 11.46%. This prediction currently runs until 29.02.24. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 70% into this prediction
Performance without dividends (%)
Name 1w
Reata Pharmaceuticals Inc 9.278%
iShares Core DAX® 0.769%
iShares Nasdaq 100 3.939%
iShares Nikkei 225® -0.063%
iShares S&P 500 1.895%

According to BiotechBee what are the pros and cons of Reata Pharmaceuticals Inc for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Reata Pharmaceuticals Inc diskutieren
Prediction Sell
Perf. (%) 11.46%
Target price 25.000
Change
Ends at 29.02.24

Sell mit Kursziel 25,0

Stopped prediction by BiotechBee for Reata Pharmaceuticals Inc

buy
Reata Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€25.60
08.09.22
€40.00
31.12.24
35.94%
21.10.22

Could be very worthwhile Investment >20% year